DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(27 sites)

United Kingdom

Belfast City Hospital, Belfast

University Hospital Birmingham, Birmingham

Birmingham Children's Hospital, Birmingham

Bristol Royal Hospital for Children, Bristol

Bristol Haematology and Oncology Centre, Bristol